Karen Hunady | Director-Corporate Communications & Investor Relations |
Nancy Simonian | President & Chief Executive Officer |
David Roth | Chief Medical Officer |
Jason Haas | Chief Financial Officer |
Edward Tenthoff | Piper Sandler |
Philip Nadeau | Cowen |
Good day, and welcome to the Q3 2022 Syros Pharmaceuticals, Inc. Earnings Conference Call. At this time, all participants are in listen-only mode. After the speaker presentation, there will be a question-and-answer session. [Operator Instructions].